LRA-61320-09814 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-13
Dose 1 — Pfizer-BioNTech
2021-04-02
Dose 2 — Pfizer-BioNTech
2021-04-03
Registered in v-safe
2021-04-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Nausea

Adult check-in
2021-04-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-09
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-16
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-07-04
Survey response — 3 months, dose 2
MedDRA: Nasopharyngitis — Feeling: Fair

Free text: Cold symptoms

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-10-01
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-01
Dose 3 — Pfizer-BioNTech
2022-04-02
Survey response — 12 months, dose 2
MedDRA: Abortion spontaneous, Asthma, Nasopharyngitis, Pre-existing disease — Feeling: Good · Be unable to work or attend school

Free text: Miscarriage Bad colds Worse Asthma

MedDRA releases: 2024-11 · check-in free text available
2022-05-02
Survey response — 6 months, dose 3
MedDRA: Fatigue, Insomnia, Palpitations — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Tired, racing heart, cannot sleep.

MedDRA releases: 2024-11 · check-in free text available
2022-05-02
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-05-03
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-13	Pfizer-BioNTech
2	2021-04-02	Pfizer-BioNTech
3	2021-11-01	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-05-02	Unsuccessful

Free text

Release 9 — 3 months, dose 2

2021-07-04

Symptoms: Cold symptoms

Release 11 — 12 months, dose 2

2022-04-02

Symptoms: Miscarriage Bad colds Worse Asthma

Release 11 — 6 months, dose 3

2022-05-02

Symptoms: Tired, racing heart, cannot sleep.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abortion spontaneous	·	·	✓
SD	Asthma	·	·	✓
SD	Fatigue	·	·	✓
SD	Insomnia	·	·	✓
SD	Nasopharyngitis	✓	✓	✓
SD	Palpitations	·	·	✓
SD	Pre-existing disease	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release